Some advocates are calling the Food and Drug Administration’s historical hesitation to approve a drug that would treat low sex drive in women sexist; others are saying the development of the medication itself is sexist. Who’s in the right?

Dozens of college students and reproductive justice activists met with lawmakers in Austin Thursday morning, asking them to support comprehensive sex ed, increase access to legal abortion care, and give doctors more leeway to make medically sound decisions about their patients.

Social conservatives have been getting more obvious about bullying women into accepting their self-sacrificing, self-effacing model of womanhood. They’re having to get louder because fewer women are listening.

At The New Republic, writer Monica Potts recently positioned trans activism at women’s colleges as a distraction from feminism. In reality, the misogyny trans women face is similar to, if not worse than, the kind Potts is fighting.

A New York Times writer recently found that users identifying as men asked more questions of search engines about their penises than about their lungs, livers, feet, ears, noses, throats, and brains combined.

A bill to reform the Toxic Substances Control Act is likely to be introduced in Congress next week. Given some chemicals’ effects on causing early puberty in girls, reproductive health advocates should demand strong regulation that removes harmful chemical substances from the market.